Skip to main content
GENETIC TECHNOLOGIES LIMITED logo

GENETIC TECHNOLOGIES LIMITED — Investor Relations & Filings

Ticker · GTG ISIN · AU000000GTG7 LEI · 529900YYKY7FRC90M744 ASX Human health and social work activities
Open in API
Filings indexed 1,303 across all filing types
Latest filing 2004-09-21 Capital/Financing Update
Country AU Australia
Listing ASX GTG

About GENETIC TECHNOLOGIES LIMITED

https://gtglabs.com/

Genetic Technologies Limited is a molecular diagnostics company focused on the development and commercialization of predictive genetic risk assessment tools. The company specializes in the geneType platform, which integrates clinical risk factors with polygenic risk scores to provide comprehensive risk assessments for various chronic diseases. Its portfolio includes tests for breast cancer, colorectal cancer, prostate cancer, melanoma, type 2 diabetes, and coronary artery disease. By identifying individuals at high risk of developing these conditions, the company enables healthcare providers to implement personalized screening and preventative health strategies. Genetic Technologies Limited serves clinicians and patients globally, aiming to improve health outcomes through early detection and precision medicine.

Recent filings

Filing Released Lang Actions
Significant License Agreement with Genzyme Corp of USA 1
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated September 22, 2004, reporting a significant license agreement between Genetic Technologies Limited and Genzyme Corporation. It details the terms of the license, including fees and geographic scope, and describes the strategic alliance intentions. The content is an announcement of a business agreement related to licensing and strategic partnership, not a financial report, earnings release, or regulatory filing. It does not contain financial statements or detailed financial data. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to licensing revenue and strategic business development.
2004-09-21 English
Trading Halt 2 pages ?Kb
Regulatory Filings Classification · 95% confidence The document is a market release dated 21 September 2004 from Genetic Technologies Limited requesting a trading halt pending a significant announcement about a new license agreement in the USA. It is a short notice about the trading halt and does not contain financial data, management discussion, or detailed report content. It is an announcement related to trading status rather than a financial report or detailed corporate filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2004-09-20 English
GTG Reports Further Positive Developments in Legal Action 14 pages ?Kb
Legal Proceedings Report Classification · 95% confidence The document is an ASX announcement dated September 16, 2004, reporting on legal developments in a patent dispute involving Genetic Technologies Limited. It discusses a court ruling on the interpretation of patent claim terms and includes excerpts from the court's Claim Construction Order. The content focuses on legal proceedings related to patent protection, not financial results, management changes, or shareholder matters. The document is a detailed legal update rather than a full audit report or annual report. It is not a brief announcement but a substantive legal proceedings report. Therefore, the most appropriate classification is Legal Proceedings Report (LTR).
2004-09-15 English
Reponse to Stock Exchange Price Query 4 pages ?Kb
Regulatory Filings Classification · 95% confidence The document is a formal response letter from Genetic Technologies Limited to the Australian Stock Exchange (ASX) regarding a price and volume enquiry about the company's securities. It addresses questions about recent share price movements, potential undisclosed information, compliance with listing rules, and trading halt considerations. The content is focused on regulatory compliance and market communication rather than financial results, management changes, or detailed financial data. The document is not a financial report, earnings release, or management discussion but a regulatory response to a stock exchange inquiry about share price movements. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2004-09-09 English
Appendix 3B - Staff Share Plan 9 pages ?Kb
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3B' and is described as a 'New issue announcement, application for quotation of additional securities and agreement.' It details the issuance of unlisted employee share options under a staff share plan, including the number of securities, exercise price, expiry dates, and other terms. The document references ASX (Australian Securities Exchange) rules and is clearly an announcement related to new securities issuance. There is no financial performance data, management discussion, or audit information. The content fits the definition of a Share Issue/Capital Change announcement, which covers new share issues or stock options. The document length is substantial but the content is focused on the issuance details rather than a full report or regulatory filing. Therefore, the appropriate classification is Share Issue/Capital Change (SHA).
2004-09-05 English
Reports on Current Status of Legal Action to Protect Patents 2 pages ?Kb
Legal Proceedings Report Classification · 100% confidence The document is an ASX announcement dated September 3, 2004, providing an update on the status of legal actions related to the company's patents. It discusses ongoing patent infringement lawsuits, settlements, a recent court hearing (Markman hearing), and other legal matters including a statement of claim from a health board. The content focuses exclusively on legal proceedings and patent litigation updates, without any financial data, earnings information, or management changes. It is not a full annual or interim report, nor an earnings release or investor presentation. The document is a standalone update on legal matters, fitting the definition of a Legal Proceedings Report (LTR).
2004-09-02 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.